Ligand validation:6MB5

NMY: NEOMYCIN

NMY is a Ligand Of Interest in 6MB5 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6MB5_NMY_A_301	70%	7%	0.105	0.921	3.79	1.08	15	3	2	0	100%	1
6MB9_NMY_D_302	58%	6%	0.144	0.922	3.96	1.15	17	5	3	0	100%	1
6NMM_NMY_A_800	91%	7%	0.069	0.956	3.87	1.07	15	3	4	0	100%	1
4LFB_NMY_A_1822	79%	30%	0.105	0.951	1.3	1.49	4	12	3	0	100%	1
6P06_NMY_A_305	76%	6%	0.118	0.954	4.01	1.21	17	5	4	0	100%	1
4V9C_NMY_DA_3188	64%	10%	0.108	0.907	2.24	2.03	13	24	21	0	100%	0.79
5IQE_NMY_D_600	63%	56%	0.156	0.953	0.35	1.32	-	8	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.